Publications

Analytical and clinical validity of Northstar Select, a quantitatively enhanced liquid biopsy assay for comprehensive genomic profiling of solid tumors

AACR Poster Session

Analytical and clinical validity of Northstar Select, a quantitatively enhanced liquid biopsy assay for comprehensive genomic profiling of solid tumors

Analytical and clinical validity of Northstar Select, a quantitatively enhanced liquid biopsy assay for comprehensive genomic profiling of solid tumors

AACR Poster Session

Analytical and clinical validity of Northstar Select, a quantitatively enhanced liquid biopsy assay for comprehensive genomic profiling of solid tumors

Clinical Validation of Northstar Response, a novel methylated ctDNA therapy response monitoring assay in patients with advanced GI cancer undergoing active treatment

ASCO GI 2024 Poster Session

Clinical Validation of Northstar Response, a novel methylated ctDNA therapy response monitoring assay in patients with advanced GI cancer undergoing active treatment

Clinical Validation of Northstar Response, a novel methylated ctDNA therapy response monitoring assay in patients with advanced GI cancer undergoing active treatment

ASCO GI 2024 Poster Session

Clinical Validation of Northstar Response, a novel methylated ctDNA therapy response monitoring assay in patients with advanced GI cancer undergoing active treatment

Performance of single-gene noninvasive prenatal testing for autosomal recessive conditions in a general population setting

UNITY Fetal Risk Screen Clinical Validity and Utility

Prenatal Diagnosis

Performance of single-gene noninvasive prenatal testing for autosomal recessive conditions in a general population setting

Performance of single-gene noninvasive prenatal testing for autosomal recessive conditions in a general population setting

UNITY Fetal Risk Screen Clinical Validity and Utility

Prenatal Diagnosis

Performance of single-gene noninvasive prenatal testing for autosomal recessive conditions in a general population setting

Validation of a Non-invasive Prenatal Test for Fetal RhD, C, c, E, Kell and FyA Antigens

Validation for Red Blood Cell Fetal Antigen NIPT

Scientific Reports

Validation of a Non-invasive Prenatal Test for Fetal RhD, C, c, E, Kell and FyA Antigens

Validation of a Non-invasive Prenatal Test for Fetal RhD, C, c, E, Kell and FyA Antigens

Validation for Red Blood Cell Fetal Antigen NIPT

Scientific Reports

Validation of a Non-invasive Prenatal Test for Fetal RhD, C, c, E, Kell and FyA Antigens

Methylated ctDNA as a biomarker for detecting previously undetectable clinically significant somatic mutations.

ASCO 2023 E-Publication

Methylated ctDNA as a biomarker for detecting previously undetectable clinically significant somatic mutations.

Methylated ctDNA as a biomarker for detecting previously undetectable clinically significant somatic mutations.

ASCO 2023 E-Publication

Methylated ctDNA as a biomarker for detecting previously undetectable clinically significant somatic mutations.

Methylated ctDNA dynamics correspond with clinical tumor load in metastatic lung cancer patients on therapy

AACR 2023 Poster Session

Methylated ctDNA dynamics correspond with clinical tumor load in metastatic lung cancer patients on therapy

Methylated ctDNA dynamics correspond with clinical tumor load in metastatic lung cancer patients on therapy

AACR 2023 Poster Session

Methylated ctDNA dynamics correspond with clinical tumor load in metastatic lung cancer patients on therapy

Maternal carrier screening with single-gene NIPS provides accurate fetal risk assessments for recessive conditions

Clinical Validity and Utility for UNITY Carrier Screen with sgNIPT

Genetics in Medicine

Maternal carrier screening with single-gene NIPS provides accurate fetal risk assessments for recessive conditions

Maternal carrier screening with single-gene NIPS provides accurate fetal risk assessments for recessive conditions

Clinical Validity and Utility for UNITY Carrier Screen with sgNIPT

Genetics in Medicine

Maternal carrier screening with single-gene NIPS provides accurate fetal risk assessments for recessive conditions

Validation of single-gene noninvasive prenatal testing for sickle cell disease

Sickle Cell Disease Validation

American Journal of Hematology

Validation of single-gene noninvasive prenatal testing for sickle cell disease

Validation of single-gene noninvasive prenatal testing for sickle cell disease

Sickle Cell Disease Validation

American Journal of Hematology

Validation of single-gene noninvasive prenatal testing for sickle cell disease